HLB's U.S. subsidiary Eleva Therapeutics received a Complete Response Letter (CRL) from the FDA regarding the approval of its liver cancer drug Rivoceranib. The letter cited issues with the Good Manufacturing Practice (GMP) of its partner, Chinese company Hengrui Medicine's manufacturing facility. This marks the second rejection for the drug.
David Hencke, a celebrated Guardian journalist known for uncovering major political scandals including the cash-for-questions affair, has died of liver cancer at 79.
University of Washington researchers have detected Echinococcus multilocularis, a disease-causing tapeworm, in West Coast wildlife for the first time. The parasite, previously found in Canada and the Midwest, can cause fatal, cancer-like cysts in humans and animals.
Taiwan's Hepatic Disease Prevention and Treatment Foundation launched the 'iGood Liver AI' system to aid doctors in identifying potential liver tumors via ultrasound, aiming to improve early detection rates and reduce mortality. 50 sets are donated to rural clinics.
Taiwan is advancing its hepatitis C elimination efforts and seeking WHO certification. The next focus is on expanding Hepatitis B treatment and early liver cancer detection, with proposed changes to national health insurance drug coverage expected to benefit 17,000-30,000 patients.
Shoaib Ibrahim's father has been admitted to the ICU after suffering another brain stroke. The next 24 hours are crucial for his health. This follows a similar incident in 2021, and the family has also faced health challenges with Dipika Kakar's past cancer diagnosis.
The Li Ka Shing Foundation will subsidize liver cancer surgeries for 200 patients over three years, covering HK$210,000 of the HK$260,000 cost for histotripsy treatment, a non-invasive ultrasound procedure.
